Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Shares Outstanding (Diluted Average) (2016 - 2025)

Historic Shares Outstanding (Diluted Average) for Dare Bioscience (DARE) over the last 8 years, with Q3 2025 value amounting to $12.8 million.

  • Dare Bioscience's Shares Outstanding (Diluted Average) rose 4688.72% to $12.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 million, marking a year-over-year increase of 4688.72%. This contributed to the annual value of $8.5 million for FY2024, which is 1679.86% up from last year.
  • Latest data reveals that Dare Bioscience reported Shares Outstanding (Diluted Average) of $12.8 million as of Q3 2025, which was up 4688.72% from $8.9 million recorded in Q2 2025.
  • In the past 5 years, Dare Bioscience's Shares Outstanding (Diluted Average) ranged from a high of $85.6 million in Q3 2022 and a low of $7.2 million during Q2 2023
  • Its 5-year average for Shares Outstanding (Diluted Average) is $38.9 million, with a median of $12.8 million in 2025.
  • In the last 5 years, Dare Bioscience's Shares Outstanding (Diluted Average) soared by 12405.71% in 2021 and then plummeted by 9150.98% in 2023.
  • Over the past 5 years, Dare Bioscience's Shares Outstanding (Diluted Average) (Quarter) stood at $61.2 million in 2021, then skyrocketed by 38.29% to $84.6 million in 2022, then tumbled by 91.4% to $7.3 million in 2023, then increased by 16.8% to $8.5 million in 2024, then skyrocketed by 50.11% to $12.8 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $12.8 million in Q3 2025, compared to $8.9 million in Q2 2025 and $8.8 million in Q1 2025.